Impact of a Histamine H2 Receptor Antagonist (H2RA) on the Pharmacokinetics (PK) of Telaglenastat in Healthy Subjects
Clinical trial NCT04540965 · COMPLETED
Trial details
- NCT number
- NCT04540965
- Sponsor
- Calithera Biosciences, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-22
- Primary completion
- 2020-12-08
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.